CTSG and COVID-19: In this regard, it would be beneficial if Nafamostat also impairs the proteolytic activity of CatG (secreted or bound on the cell surface of neutrophils), thereby interfering with severe complications of COVID-19, but this hypothesis needs to be elucidated.